Literature DB >> 27071091

Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance.

Matilda Rentoft1, Kristoffer Lindell2, Phong Tran2, Anna Lena Chabes2, Robert J Buckland2, Danielle L Watt2, Lisette Marjavaara2, Anna Karin Nilsson2, Beatrice Melin3, Johan Trygg4, Erik Johansson2, Andrei Chabes5.   

Abstract

Even small variations in dNTP concentrations decrease DNA replication fidelity, and this observation prompted us to analyze genomic cancer data for mutations in enzymes involved in dNTP metabolism. We found that sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1), a deoxyribonucleoside triphosphate triphosphohydrolase that decreases dNTP pools, is frequently mutated in colon cancers, that these mutations negatively affect SAMHD1 activity, and that several SAMHD1 mutations are found in tumors with defective mismatch repair. We show that minor changes in dNTP pools in combination with inactivated mismatch repair dramatically increase mutation rates. Determination of dNTP pools in mouse embryos revealed that inactivation of one SAMHD1 allele is sufficient to elevate dNTP pools. These observations suggest that heterozygous cancer-associated SAMHD1 mutations increase mutation rates in cancer cells.

Entities:  

Keywords:  DNA replication fidelity; colon cancer; dNTP pools

Mesh:

Substances:

Year:  2016        PMID: 27071091      PMCID: PMC4855590          DOI: 10.1073/pnas.1519128113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  69 in total

1.  Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells.

Authors:  Pelle Håkansson; Anders Hofer; Lars Thelander
Journal:  J Biol Chem       Date:  2006-01-24       Impact factor: 5.157

Review 2.  Deoxyribonucleotide metabolism, mutagenesis and cancer.

Authors:  Christopher K Mathews
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

Review 3.  Mutagenesis and deoxyribonucleotide pool imbalance.

Authors:  B A Kunz
Journal:  Mutat Res       Date:  1988 Jul-Aug       Impact factor: 2.433

4.  The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells.

Authors:  Elisa Franzolin; Giovanna Pontarin; Chiara Rampazzo; Cristina Miazzi; Paola Ferraro; Elisa Palumbo; Peter Reichard; Vera Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

5.  Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Dorothee Wernicke; Hansjuerg Alder; Stefan Costinean; Stefano Volinia; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

6.  Highly mutagenic and severely imbalanced dNTP pools can escape detection by the S-phase checkpoint.

Authors:  Dinesh Kumar; Jörgen Viberg; Anna Karin Nilsson; Andrei Chabes
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

7.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

8.  Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice.

Authors:  Andres J Lopez-Contreras; Julia Specks; Jacqueline H Barlow; Chiara Ambrogio; Claus Desler; Svante Vikingsson; Sara Rodrigo-Perez; Henrik Green; Lene Juel Rasmussen; Matilde Murga; André Nussenzweig; Oscar Fernandez-Capetillo
Journal:  Genes Dev       Date:  2015-04-01       Impact factor: 11.361

9.  Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection.

Authors:  Junpeng Yan; Sarabpreet Kaur; Maria DeLucia; Caili Hao; Jennifer Mehrens; Chuanping Wang; Marcin Golczak; Krzysztof Palczewski; Angela M Gronenborn; Jinwoo Ahn; Jacek Skowronski
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

Review 10.  Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications.

Authors:  Rebecca Kohnken; Karthik M Kodigepalli; Li Wu
Journal:  Mol Cancer       Date:  2015-09-29       Impact factor: 27.401

View more
  51 in total

1.  The SAMHD1 dNTP Triphosphohydrolase Is Controlled by a Redox Switch.

Authors:  Christopher H Mauney; LeAnn C Rogers; Reuben S Harris; Larry W Daniel; Nelmi O Devarie-Baez; Hanzhi Wu; Cristina M Furdui; Leslie B Poole; Fred W Perrino; Thomas Hollis
Journal:  Antioxid Redox Signal       Date:  2017-04-18       Impact factor: 8.401

2.  Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.

Authors:  Karthik M Kodigepalli; Minghua Li; Shan-Lu Liu; Li Wu
Journal:  Cell Cycle       Date:  2016-12-08       Impact factor: 4.534

3.  Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.

Authors:  Nikolas Herold; Sean G Rudd; Linda Ljungblad; Kumar Sanjiv; Ida Hed Myrberg; Cynthia B J Paulin; Yaser Heshmati; Anna Hagenkort; Juliane Kutzner; Brent D G Page; José M Calderón-Montaño; Olga Loseva; Ann-Sofie Jemth; Lorenzo Bulli; Hanna Axelsson; Bianca Tesi; Nicholas C K Valerie; Andreas Höglund; Julia Bladh; Elisée Wiita; Mikael Sundin; Michael Uhlin; Georgios Rassidakis; Mats Heyman; Katja Pokrovskaja Tamm; Ulrika Warpman-Berglund; Julian Walfridsson; Sören Lehmann; Dan Grandér; Thomas Lundbäck; Per Kogner; Jan-Inge Henter; Thomas Helleday; Torsten Schaller
Journal:  Nat Med       Date:  2017-01-09       Impact factor: 53.440

4.  MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.

Authors:  Rebecca Kohnken; Karthik M Kodigepalli; Anjali Mishra; Pierluigi Porcu; Li Wu
Journal:  Leuk Res       Date:  2016-11-17       Impact factor: 3.156

5.  SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous Recombination.

Authors:  Waaqo Daddacha; Allyson E Koyen; Amanda J Bastien; PamelaSara E Head; Vishal R Dhere; Geraldine N Nabeta; Erin C Connolly; Erica Werner; Matthew Z Madden; Michele B Daly; Elizabeth V Minten; Donna R Whelan; Ashley J Schlafstein; Hui Zhang; Roopesh Anand; Christine Doronio; Allison E Withers; Caitlin Shepard; Ranjini K Sundaram; Xingming Deng; William S Dynan; Ya Wang; Ranjit S Bindra; Petr Cejka; Eli Rothenberg; Paul W Doetsch; Baek Kim; David S Yu
Journal:  Cell Rep       Date:  2017-08-22       Impact factor: 9.423

6.  SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft mice.

Authors:  Karthik M Kodigepalli; Minghua Li; Serena Bonifati; Amanda R Panfil; Patrick L Green; Shan-Lu Liu; Li Wu
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

7.  Single-Stranded Nucleic Acids Bind to the Tetramer Interface of SAMHD1 and Prevent Formation of the Catalytic Homotetramer.

Authors:  Kyle J Seamon; Namandjé N Bumpus; James T Stivers
Journal:  Biochemistry       Date:  2016-10-27       Impact factor: 3.162

8.  SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis.

Authors:  Karthik M Kodigepalli; Serena Bonifati; Nagaraja Tirumuru; Li Wu
Journal:  Cell Cycle       Date:  2018-07-17       Impact factor: 4.534

9.  SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.

Authors:  Constanze Schneider; Thomas Oellerich; Hanna-Mari Baldauf; Sarah-Marie Schwarz; Dominique Thomas; Robert Flick; Hanibal Bohnenberger; Lars Kaderali; Lena Stegmann; Anjali Cremer; Margarethe Martin; Julian Lohmeyer; Martin Michaelis; Veit Hornung; Christoph Schliemann; Wolfgang E Berdel; Wolfgang Hartmann; Eva Wardelmann; Federico Comoglio; Martin-Leo Hansmann; Alexander F Yakunin; Gerd Geisslinger; Philipp Ströbel; Nerea Ferreirós; Hubert Serve; Oliver T Keppler; Jindrich Cinatl
Journal:  Nat Med       Date:  2016-12-19       Impact factor: 53.440

Review 10.  SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.

Authors:  Christopher H Mauney; Thomas Hollis
Journal:  Autoimmunity       Date:  2018-03-27       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.